TCL Archive In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor January 6, 1989
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC December 19, 2014
TCL Archive Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review. November 14, 2003
TCL Archive Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.” March 9, 2007
